Marked increase of β-amyloid(1–42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury

[1]  K. Blennow,et al.  Measurement of α- and β-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients , 2003, Experimental Neurology.

[2]  D. Graham,et al.  Amyloid β accumulation in axons after traumatic brain injury in humans , 2003 .

[3]  A. Hamberger,et al.  Redistribution of neurofilaments and accumulation of beta-amyloid protein after brain injury by rotational acceleration of the head. , 2003, Journal of neurotrauma.

[4]  B. Asgeirsson,et al.  Volume‐targeted therapy of increased intracranial pressure: the Lund concept unifies surgical and non‐surgical treatments , 2002, Acta anaesthesiologica Scandinavica.

[5]  J. Trojanowski,et al.  Repetitive Mild Brain Trauma Accelerates Aβ Deposition, Lipid Peroxidation, and Cognitive Impairment in a Transgenic Mouse Model of Alzheimer Amyloidosis , 2002, The Journal of Neuroscience.

[6]  B. Strooper,et al.  Proteolytic processing and cell biological functions of the amyloid precursor protein. , 2000, Journal of cell science.

[7]  G. Cole,et al.  β‐Amyloid (Aβ)42(43), Aβ42, Aβ40 and apoE immunostaining of plaques in fatal head injury , 2000, Neuropathology and applied neurobiology.

[8]  P. Mehta,et al.  Traumatic Brain Injury Elevates the Alzheimer's Amyloid Peptide Aβ42 in Human CSF: A Possible Role for Nerve Cell Injury , 2000, Annals of the New York Academy of Sciences.

[9]  K. Blennow,et al.  Standardization of measurement of β-amyloid(1-42) in cerebrospinal fluid and plasma , 2000, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[10]  H. Wiśniewski,et al.  Plasma amyloid β‐peptide 1–42 and incipient Alzheimer's disease , 1999 .

[11]  E. Matsubara,et al.  Lipoprotein‐free amyloidogenic peptides in plasma are elevated in patients with sporadic Alzheimer's disease and Down's syndrome , 1999, Annals of neurology.

[12]  P. Mehta,et al.  Traumatic Brain Injury Increases β‐Amyloid Peptide 1‐42 in Cerebrospinal Fluid , 1998 .

[13]  J. Trojanowski,et al.  Brain trauma induces massive hippocampal neuron death linked to a surge in beta-amyloid levels in mice overexpressing mutant amyloid precursor protein. , 1998, The American journal of pathology.

[14]  K. Tashiro,et al.  Autosomal dominant spastic paraplegia linked to chromosome 2p: clinical and genetic studies of a large Japanese pedigree , 1997, Journal of the Neurological Sciences.

[15]  J. Povlishock,et al.  A mechanistic analysis of nondisruptive axonal injury: a review. , 1997, Journal of neurotrauma.

[16]  M. Mattson,et al.  Increased Activity‐Regulating and Neuroprotective Efficacy of α‐Secretase‐Derived Secreted Amyloid Precursor Protein Conferred by a C‐Terminal Heparin‐Binding Domain , 1996, Journal of neurochemistry.

[17]  E. Oguni,et al.  Amyloid β protein in plasma from patients with sporadic Alzheimer's disease , 1996, Journal of the Neurological Sciences.

[18]  R. Xue,et al.  Amyloid Precursor Protein Metabolism in Primary Cell Cultures of Neurons, Astrocytes, and Microglia , 1996, Journal of neurochemistry.

[19]  N. Ichihara,et al.  Axonal degeneration promotes abnormal accumulation of amyloid β-protein in ascending gracile tract of gracile axonal dystrophy (GAD) mouse , 1995, Brain Research.

[20]  L. Mucke,et al.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.

[21]  D. Graham,et al.  Increased numbers of βAPP‐immunoreactive neurones in the entorhinal cortex after head injury , 1994 .

[22]  N. Suzuki,et al.  Biochemical evidence for the long-tail form (Aβ1-42/43) of amyloid β protein as a seed molecule in cerebral deposits of alzheimer′s disease , 1994 .

[23]  T. Iwatsubo,et al.  Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43) , 1994, Neuron.

[24]  L. Murray,et al.  Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[25]  D. Graham,et al.  β-Amyloid precursor protein (βAPP) as a marker for axonal injury after head injury , 1993, Neuroscience Letters.

[26]  L. Thal,et al.  Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide , 1993, Nature.

[27]  D. Selkoe,et al.  Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.

[28]  A. Hofman,et al.  Head trauma and the risk of Alzheimer's disease. , 1992, American journal of epidemiology.

[29]  T. Kitamoto,et al.  Alzheimer's amyloid precursor protein accumulates within axonal swellings in human brain lesions , 1992, Neuroscience Letters.

[30]  N. Otsuka,et al.  Rapid appearance of β-amyloid precursor protein immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury , 1991, Brain Research.

[31]  S. Hirai,et al.  Expression of APP in the early stage of brain damage , 1991, Brain Research.

[32]  Anthony Marmarou,et al.  A new classification of head injury based on computerized tomography , 1991 .

[33]  J. Povlishock,et al.  Traumatically Induced Axonal Injury: Pathogenesis and Pathobiological Implications , 1991, Brain pathology.

[34]  D. Allsop,et al.  The occult aftermath of boxing. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[35]  R. Neve,et al.  The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway. , 1990, The Journal of biological chemistry.

[36]  D. Price,et al.  Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Robert B. Nelson,et al.  Expression of β-amyloid precursor protein in reactive astrocytes following neuronal damage , 1989, Neuron.

[38]  T. Tokuda,et al.  Re-examination of ex-boxers' brains using immunohistochemistry with antibodies to amyloid β-protein and tau protein , 2004, Acta Neuropathologica.

[39]  D. Graham,et al.  Amyloid beta accumulation in axons after traumatic brain injury in humans. , 2003, Journal of neurosurgery.

[40]  H. Wiśniewski,et al.  Plasma and cerebrospinal fluid Levels of amyloid β proteins 1-40 and 1-42 in Alzheimer disease , 2000 .

[41]  K. Blennow,et al.  Cerebrospinal fluid markers for Alzheimer's disease evaluated after acute ischemic stroke. , 2000, Journal of Alzheimer's disease : JAD.

[42]  K. Blennow,et al.  No association between the α2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression , 2000, Journal of Neural Transmission.

[43]  S A Small,et al.  Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease. , 1999, Annals of neurology.

[44]  P. Mehta,et al.  Traumatic brain injury increases beta-amyloid peptide 1-42 in cerebrospinal fluid. , 1998, Journal of neurochemistry.

[45]  D. Graham,et al.  Altered beta-APP metabolism after head injury and its relationship to the aetiology of Alzheimer's disease. , 1996, Acta neurochirurgica. Supplement.

[46]  D. Mann,et al.  Presence of soluble amyloid β–peptide precedes amyloid plaque formation in Down's syndrome , 1996, Nature Medicine.

[47]  E. Oguni,et al.  Amyloid beta protein in plasma from patients with sporadic Alzheimer's disease. , 1996, Journal of the neurological sciences.

[48]  D. Graham,et al.  Altered β-APP Metabolism After Head Injury and its Relationship to the Aetiology of Alzheimer’s Disease , 1996 .

[49]  T. Iwatsubo,et al.  Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). , 1994, Neuron.

[50]  N. Suzuki,et al.  Biochemical evidence for the long-tail form (A beta 1-42/43) of amyloid beta protein as a seed molecule in cerebral deposits of Alzheimer's disease. , 1994, Biochemical and biophysical research communications.

[51]  D. Graham,et al.  Increased numbers of beta APP-immunoreactive neurones in the entorhinal cortex after head injury. , 1994, Neuroreport.

[52]  L. Thal,et al.  Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. , 1993, Nature.

[53]  D. Graham,et al.  Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. , 1993, Neuroscience letters.

[54]  G. Glenner,et al.  Alzheimerʼs disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1988 .